-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Tag Archives: PTO
BIO Hosts U.S./China Biotechnology Examiner Workshop with U.S. Patent and Trademark Office and China’s State Intellectual Property Office
Press Release: WASHINGTON, D.C. (Tuesday, April 05, 2011) – The Biotechnology Industry Organization (BIO) hosted a U.S./China Biotechnology Examiner Workshop with U.S. Patent and Trademark Office (PTO) and China’s State Intellectual Property Office (SIPO) on March 28, 2011 in Beijing, China. The workshop which was organized by BIO for SIPO examiners, focused on biotechnology patenting and encouraged bilateral cooperation between SIPO and the USPTO.“BIO recognizes the commitment on behalf of the Chinese Government and Read More >
Patently BIOtech
Leave a comment
Email This Post
Tags: Access and Benefit Sharing, Beijing, BIO, biotechnology, Biotechnology Industry Organization, China, Chinese Patent Office, claim homology, enablement, Events, Examiner workshop, genetic resources, patent, patent disclosure, patent law, PTO, sequence homology, SIPO, United States Patent and Trademark Office, USPTO, written description
Tags: Access and Benefit Sharing, Beijing, BIO, biotechnology, Biotechnology Industry Organization, China, Chinese Patent Office, claim homology, enablement, Events, Examiner workshop, genetic resources, patent, patent disclosure, patent law, PTO, sequence homology, SIPO, United States Patent and Trademark Office, USPTO, written description
BIO’s Amicus Brief: Microsoft v. i4i
The Biotechnology Industry Organization, along with AUTM and CropLife International, filed an amicus brief in the Microsoft v. i4i Supreme Court case. This case is widely viewed as one of the most fundamental and important patent cases to reach the Supreme Court in probably a decade. Most basically, this case is about the level of certainty a jury or judge must have before finding a patent invalid in litigation. Historically, the law has required a high level Read More >
Patently BIOtech
1 Comment
Email This Post
Tags: amicus brief, AUTM, BIO, biotechnology, Biotechnology Industry Organization, burden of proof, clear and convincing evidence, CropLife, i4i, Microsoft, Microsoft v. i4i, patent, Patent and Trademark Office, preponderance of the evidence, PTO, Supreme Court, USPTO
Tags: amicus brief, AUTM, BIO, biotechnology, Biotechnology Industry Organization, burden of proof, clear and convincing evidence, CropLife, i4i, Microsoft, Microsoft v. i4i, patent, Patent and Trademark Office, preponderance of the evidence, PTO, Supreme Court, USPTO
Patent Reform Bill good for Biotech
Patent Reform Passes the Senate and Moves to the House Posted by Roy Zwahlen, manager of intellectual property and technology transfer policy at BIO. On March 8th, the Senate approved the America Invents Act (S. 23) by an overwhelming vote of 95-5. BIO supports this bipartisan, consensus-oriented bill, formerly known as the Patent Reform Act of 2011. Once enacted into law, it will strengthen and improve our nation’s patent system, spurring innovation and job creation. Patents are often Read More >
Patently BIOtech
1 Comment
Email This Post
Tags: America Invents Act, best mode, BIO, BIOTECH, Biotechnology Industry, bipartisan, False marking, false patent marking, First inventor to file, First to file, first to invent, Grassley, Leahy, Patent and Trademark Office, Patent Reform, PTO, PTO Reexaminations, Senate Judiciary Comm, USPTO
Tags: America Invents Act, best mode, BIO, BIOTECH, Biotechnology Industry, bipartisan, False marking, false patent marking, First inventor to file, First to file, first to invent, Grassley, Leahy, Patent and Trademark Office, Patent Reform, PTO, PTO Reexaminations, Senate Judiciary Comm, USPTO
PTO Director Kappos Remarks at Innovation Alliance Conference: IP leads to job growth
Thank you Roger [Martin], for that kind introduction. I would like to thank the Innovation Alliance for having me in today to speak with you about intellectual property’s vital role in today’s innovation economy. America stands at a critical juncture in our economic evolution, and intellectual property will play a key role in driving our economic growth and renewal. As technological advances bring great change to the speed and complexity of American innovation, strong intellectual Read More >
Patently BIOtech
Leave a comment
Email This Post
Tags: Axletech International, backlog reduction, Bayh-Dole, Chairman Leahy, Court of Appeals for the Federal Circuit, David Kappos, Department of Commerce, Director Kappos, economic development, economic growth, Green Technology, Harvard Business Review, Innovation Alliance, Intellectual Property, International, IP policy, job growth, Obama Administration, patent, Patent Reform, patents, PTO, Track 1, United States Patent and Trademark Office, USPTO, Xencor
Tags: Axletech International, backlog reduction, Bayh-Dole, Chairman Leahy, Court of Appeals for the Federal Circuit, David Kappos, Department of Commerce, Director Kappos, economic development, economic growth, Green Technology, Harvard Business Review, Innovation Alliance, Intellectual Property, International, IP policy, job growth, Obama Administration, patent, Patent Reform, patents, PTO, Track 1, United States Patent and Trademark Office, USPTO, Xencor
USPTO Economic Research Agenda
The USPTO has a new Office of the Chief Economist and they have recently published their research agenda. USPTO Economic Research Agenda The OCE is embarking upon an aggressive economic research program to provide evidence on a range of matters relevant to policymaking and the effect of IP on economic outcomes more generally. These include: (1) Relating IP to economic growth, performance and employment, including: (a) IP and entrepreneurship (b) IP and wider Read More >
